Cargando…
EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells
Background: Mito-metformin10 (MM10), synthesized by attaching a triphenylphosphonium cationic moiety via a 10-carbon aliphatic side chain to metformin, is a mitochondria-targeted analog of metformin that was recently demonstrated to alter mitochondrial function and proliferation in pancreatic ductal...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504708/ https://www.ncbi.nlm.nih.gov/pubmed/36144606 http://dx.doi.org/10.3390/molecules27185872 |
_version_ | 1784796284910043136 |
---|---|
author | d’Hose, Donatienne Mathieu, Barbara Mignion, Lionel Hardy, Micael Ouari, Olivier Jordan, Bénédicte F. Sonveaux, Pierre Gallez, Bernard |
author_facet | d’Hose, Donatienne Mathieu, Barbara Mignion, Lionel Hardy, Micael Ouari, Olivier Jordan, Bénédicte F. Sonveaux, Pierre Gallez, Bernard |
author_sort | d’Hose, Donatienne |
collection | PubMed |
description | Background: Mito-metformin10 (MM10), synthesized by attaching a triphenylphosphonium cationic moiety via a 10-carbon aliphatic side chain to metformin, is a mitochondria-targeted analog of metformin that was recently demonstrated to alter mitochondrial function and proliferation in pancreatic ductal adenocarcinoma. Here, we hypothesized that this compound may decrease the oxygen consumption rate (OCR) in prostate cancer cells, increase the level of mitochondrial ROS, alleviate tumor hypoxia, and radiosensitize tumors. Methods: OCR and mitochondrial superoxide production were assessed by EPR (9 GHz) in vitro in PC-3 and DU-145 prostate cancer cells. Reduced and oxidized glutathione were assessed before and after MM10 exposure. Tumor oxygenation was measured in vivo using 1 GHz EPR oximetry in PC-3 tumor model. Tumors were irradiated at the time of maximal reoxygenation. Results: 24-hours exposure to MM10 significantly decreased the OCR of PC-3 and DU-145 cancer cells. An increase in mitochondrial superoxide levels was observed in PC-3 but not in DU-145 cancer cells, an observation consistent with the differences observed in glutathione levels in both cancer cell lines. In vivo, the tumor oxygenation significantly increased in the PC-3 model (daily injection of 2 mg/kg MM10) 48 and 72 h after initiation of the treatment. Despite the significant effect on tumor hypoxia, MM10 combined to irradiation did not increase the tumor growth delay compared to the irradiation alone. Conclusions: MM10 altered the OCR in prostate cancer cells. The effect of MM10 on the superoxide level was dependent on the antioxidant capacity of cell line. In vivo, MM10 alleviated tumor hypoxia, yet without consequence in terms of response to irradiation. |
format | Online Article Text |
id | pubmed-9504708 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95047082022-09-24 EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells d’Hose, Donatienne Mathieu, Barbara Mignion, Lionel Hardy, Micael Ouari, Olivier Jordan, Bénédicte F. Sonveaux, Pierre Gallez, Bernard Molecules Article Background: Mito-metformin10 (MM10), synthesized by attaching a triphenylphosphonium cationic moiety via a 10-carbon aliphatic side chain to metformin, is a mitochondria-targeted analog of metformin that was recently demonstrated to alter mitochondrial function and proliferation in pancreatic ductal adenocarcinoma. Here, we hypothesized that this compound may decrease the oxygen consumption rate (OCR) in prostate cancer cells, increase the level of mitochondrial ROS, alleviate tumor hypoxia, and radiosensitize tumors. Methods: OCR and mitochondrial superoxide production were assessed by EPR (9 GHz) in vitro in PC-3 and DU-145 prostate cancer cells. Reduced and oxidized glutathione were assessed before and after MM10 exposure. Tumor oxygenation was measured in vivo using 1 GHz EPR oximetry in PC-3 tumor model. Tumors were irradiated at the time of maximal reoxygenation. Results: 24-hours exposure to MM10 significantly decreased the OCR of PC-3 and DU-145 cancer cells. An increase in mitochondrial superoxide levels was observed in PC-3 but not in DU-145 cancer cells, an observation consistent with the differences observed in glutathione levels in both cancer cell lines. In vivo, the tumor oxygenation significantly increased in the PC-3 model (daily injection of 2 mg/kg MM10) 48 and 72 h after initiation of the treatment. Despite the significant effect on tumor hypoxia, MM10 combined to irradiation did not increase the tumor growth delay compared to the irradiation alone. Conclusions: MM10 altered the OCR in prostate cancer cells. The effect of MM10 on the superoxide level was dependent on the antioxidant capacity of cell line. In vivo, MM10 alleviated tumor hypoxia, yet without consequence in terms of response to irradiation. MDPI 2022-09-10 /pmc/articles/PMC9504708/ /pubmed/36144606 http://dx.doi.org/10.3390/molecules27185872 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article d’Hose, Donatienne Mathieu, Barbara Mignion, Lionel Hardy, Micael Ouari, Olivier Jordan, Bénédicte F. Sonveaux, Pierre Gallez, Bernard EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells |
title | EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells |
title_full | EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells |
title_fullStr | EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells |
title_full_unstemmed | EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells |
title_short | EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells |
title_sort | epr investigations to study the impact of mito-metformin on the mitochondrial function of prostate cancer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504708/ https://www.ncbi.nlm.nih.gov/pubmed/36144606 http://dx.doi.org/10.3390/molecules27185872 |
work_keys_str_mv | AT dhosedonatienne eprinvestigationstostudytheimpactofmitometforminonthemitochondrialfunctionofprostatecancercells AT mathieubarbara eprinvestigationstostudytheimpactofmitometforminonthemitochondrialfunctionofprostatecancercells AT mignionlionel eprinvestigationstostudytheimpactofmitometforminonthemitochondrialfunctionofprostatecancercells AT hardymicael eprinvestigationstostudytheimpactofmitometforminonthemitochondrialfunctionofprostatecancercells AT ouariolivier eprinvestigationstostudytheimpactofmitometforminonthemitochondrialfunctionofprostatecancercells AT jordanbenedictef eprinvestigationstostudytheimpactofmitometforminonthemitochondrialfunctionofprostatecancercells AT sonveauxpierre eprinvestigationstostudytheimpactofmitometforminonthemitochondrialfunctionofprostatecancercells AT gallezbernard eprinvestigationstostudytheimpactofmitometforminonthemitochondrialfunctionofprostatecancercells |